CompletedNot Applicable

Vascular Anomaly Pathology and Genomics Biopsy Study

United States3 participantsStarted 2021-04-06

Plain-language summary

The purpose of this research is to gather information on the safety and effectiveness of core biopsy of vascular anomalies for clinical pathology and clinical genomics studies.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with a clinical and imaging diagnosis of a vascular anomaly. * No prior treatment for the vascular anomaly. * Subjects undergoing clinically indicated sclerotherapy, embolization and/or ablation. * Male or female with age greater than or equal to 18 years. * Capacity and willingness to provide a written informed consent.. Exclusion Criteria: * Subjects with prior treatment for their vascular anomaly. * Uncorrectable coagulopathy. * Pregnant and/or breast-feeding subjects. A negative pregnancy test within 48 hours of the procedure.

What they're measuring

Adequacy of core biopsy of vascular anomalies for clinical genomics studies

Timeframe: 18 months

Adequacy of core biopsy of vascular anomalies for clinical pathology evaluation

Timeframe: 18 months

Trial details

NCT IDNCT04836884

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-01-31

View on ClinicalTrials.gov More Vascular Malformations trials